ArticlesRegulatory August 8, 2024 Address the complexity of protein characterization Since the FDA approved the first monoclonal based therapy in 1985, mAbs have had significant… Ross Burns
BioPharmaQ&ARegulatory July 24, 2024 Quality Considerations for Using AI in Bio/Pharma In the second episode of the Ask the Expert video series, Susan J. Schniepp, distinguished… Ross Burns
ArticlesBioPharmaRegulatory March 14, 2019 Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars Biotherapeutics are an emerging class of treatment modalities that are manufactured... admin-element